Professor of Dementia
Norwich, UNITED KINGDOM
He researches groups that are at higher risk of developing dementia & works to help reduce this risk or delay the symptoms of dementia.
M.Sc., Human Biology
Norwich Evening News online
Prof Michael Hornberger said: “With the number of people living with dementia around the world set to increase to 152 million by 2025, research is our best hope of changing this future.view more
"Dementia will affect 135 million people worldwide by 2050. We need to identify people earlier to reduce their risk of developing dementia in the future,” Michael Hornberger, PhD, professor of applied dementia research, Norwich Medical School, University of East Anglia, U.K., said in a press release.view more
When Michael Hornberger, professor of applied dementia research at the University of East Anglia, suggested using mobile technology to develop a diagnostic tool for dementia, Deutsche Telekom knew they found their project. “The great thing about dementia is it really fits our brand as well because here we are dealing with people who might lose their memories in future times and can’t be part of the information society any longer,” says Schwingen. “It is in our own business interest that people maintain their brain capacities.”view more
Eastern Daily Press online
Professor Michael Hornberger, professor of dementia research at Norwich Medical School, University of East Anglia, said it was an “interesting” study which needs to be followed up with research looking at much greater numbers of people.view more
BBC News online
Michael Hornberger, a professor of applied dementia research at the University of East Anglia, said: "The amount of data that has already been generated by people playing Sea Hero Quest all around the world is phenomenal and is enabling us to reveal a vital global benchmark of how people, of all ages and from all over the use spatial navigation."view more
The Virtual Supermarket Task (VST) and Sea Hero Quest detect high-genetic-risk Alzheimer`s disease (AD). We aimed to determine their test-retest reliability in a preclinical AD population. Over two time points, separated by an 18-month period, 59 cognitively healthy individuals underwent a neuropsychological and spatial navigation assessment.
The aim of this study is to understand what makes a landmark more salient and to explore whether assessments of saliency vary between experts and non-experts. We hypothesize that non-experts’ saliency judgments will agree with those of the experts.
One of the most common definitions of saliency suggests that there are three categories for landmark saliency, these being visual, structural and cognitive. A large number of studies have focused on the afore-mentioned categories; however, there appear to be fewer studies on cognitive saliency than on the other two types of landmark saliency.
Landmarks are key elements in the wayfinding process. The impact of global and local landmarks in wayfinding has been explored by many researchers and a large body of evidence around landmarks and landmark usage has been discussed.
Amyotrophic lateral sclerosis and behavioural variant frontotemporal dementia are two different diseases recognized to overlap at clinical, pathological and genetic characteristics. Both conditions are traditionally known for relative sparing of episodic memory. However, recent studies have disputed that with the report of patients presenting with marked episodic memory impairment.